Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in children under 5 years.

Strumann, Christoph; Ranzani, Otavio; Moor, Jeanne; Berner, Reinhard; Töpfner, Nicole; Chao, Cho-Ming; Moor, Matthias B

Strumann, Christoph; Ranzani, Otavio; Moor, Jeanne; Berner, Reinhard; Töpfner, Nicole; Chao, Cho-Ming; Moor, Matthias B.

Afiliação

Strumann C; Institute of Family Medicine, University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.
Ranzani O; Barcelona Institute for Global Health, ISGlobal, Universitat Pompeu Fabra, Barcelona, Spain.
Moor J; Pulmonary Division, Heart Institute (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Berner R; Department of General Internal Medicine, Inselspital University Hospital Bern, Bern, Switzerland.
Töpfner N; Institute of Primary Health Care, University of Bern, Bern, Switzerland.
Chao CM; Department of Pediatrics, University Hospital and Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Moor MB; Department of Pediatrics, University Hospital and Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

J Clin Invest ; 133(21)2023 11 01.

Article em En | MEDLINE | ID: mdl-37669113

Assuntos

Vacina BNT162; COVID-19; Humanos; Criança; Pré-Escolar; Vacinas contra COVID-19; COVID-19/prevenção & controle

Palavras-chave

Epidemiology; Infectious disease; Vaccines

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 Limite: Child / Child, preschool / Humans Idioma: En Revista: J Clin Invest Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google